These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6207560)

  • 1. Interferon: a candidate as the endogenous substance preventing tolerance and dependence to brain opioids.
    Dafny N
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):351-7. PubMed ID: 6207560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological investigations of opiate tolerance and dependence in the central nervous system.
    Henriksen SJ
    NIDA Res Monogr; 1984; 54():239-59. PubMed ID: 6152487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids.
    Taylor DA; Fleming WW
    J Pharmacol Exp Ther; 2001 Apr; 297(1):11-8. PubMed ID: 11259522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural substrates of opioid tolerance and dependence.
    Koob GF
    NIDA Res Monogr; 1987; 76():46-52. PubMed ID: 3125470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the field of cannabinoid--opioid cross-talk.
    Robledo P; Berrendero F; Ozaita A; Maldonado R
    Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tolerance and dependence: an overview.
    Abood LG
    NIDA Res Monogr; 1984; 54():4-11. PubMed ID: 6099880
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of the cannabinoid and opioid systems in the modulation of nociception.
    Welch SP
    Int Rev Psychiatry; 2009 Apr; 21(2):143-51. PubMed ID: 19367508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid tolerance and dependence: an inevitable consequence of chronic treatment?
    Adriaensen H; Vissers K; Noorduin H; Meert T
    Acta Anaesthesiol Belg; 2003; 54(1):37-47. PubMed ID: 12703345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opioids and excessive alcohol consumption.
    Gianoulakis C
    J Psychiatry Neurosci; 1993 Jul; 18(4):148-56. PubMed ID: 7690585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance.
    Tang L; Shukla PK; Wang ZJ
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):1-4. PubMed ID: 16380209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The problem of opioid tolerance and dependence during clinical use thereof].
    Osipova NA
    Anesteziol Reanimatol; 1996; (4):17-21. PubMed ID: 8975562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in opioid tolerance and dependence].
    Chen JQ; Jin WQ
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):337-9. PubMed ID: 1966123
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid-neurotransmitter interactions: significance in analgesia, tolerance and dependence.
    Jhamandas KH
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):565-70. PubMed ID: 6152340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids: cellular mechanisms of tolerance and physical dependence.
    Bailey CP; Connor M
    Curr Opin Pharmacol; 2005 Feb; 5(1):60-8. PubMed ID: 15661627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
    Alvaro JD; Tatro JB; Quillan JM; Fogliano M; Eisenhard M; Lerner MR; Nestler EJ; Duman RS
    Mol Pharmacol; 1996 Sep; 50(3):583-91. PubMed ID: 8794897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
    Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory role of opioids in the central nervous system.
    Sheng WS; Hu S; Gekker G; Zhu S; Peterson PK; Chao CC
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):359-66. PubMed ID: 9437491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid tolerance and dependence -- do they matter?
    Jage J
    Eur J Pain; 2005 Apr; 9(2):157-62. PubMed ID: 15737807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.